PriceTargets.com logo

Core Laboratories - CLB Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $18.00
  • Forecasted Upside: -7.55%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$19.47 As of 10/30/2024 03:52 PM ET
▼ -0.03 (-0.15%)

This chart shows the closing price for CLB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Core Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLB

Analyst Price Target is $18.00
▼ -7.55% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Core Laboratories in the last 3 months. The average price target is $18.00, with a high forecast of $22.00 and a low forecast of $15.00. The average price target represents a -7.55% upside from the last price of $19.47.

This chart shows the closing price for CLB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 3 polled investment analysts is to reduce stock in Core Laboratories. This Reduce consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
5/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/26/2024Stifel NicolausBoost TargetHold ➝ Hold$18.00 ➝ $22.00
7/15/2024Bank of AmericaLower TargetUnderperform ➝ Underperform$16.00 ➝ $15.00
7/15/2024Piper SandlerLower TargetNeutral ➝ Neutral$18.00 ➝ $17.00
4/26/2024Stifel NicolausBoost TargetHold ➝ Hold$17.00 ➝ $18.00
4/15/2024Bank of AmericaLower TargetUnderperform ➝ Underperform$17.00 ➝ $16.00
2/5/2024Stifel NicolausLower TargetHold ➝ Hold$21.00 ➝ $17.00
1/29/2024Stifel NicolausLower TargetHold ➝ Hold$23.00 ➝ $21.00
9/18/2023CitigroupLower TargetSell ➝ Sell$21.00 ➝ $20.00
7/31/2023Piper SandlerBoost TargetNeutral ➝ Neutral$19.00 ➝ $21.00
6/30/2023CitigroupDowngradeNeutral ➝ Sell$22.00 ➝ $21.00
5/1/2023Piper SandlerBoost Target$18.00 ➝ $19.00
4/28/2023Stifel NicolausBoost Target$24.00 ➝ $25.00
4/18/2023Bank of AmericaDowngradeNeutral ➝ Underperform$21.50
2/7/2023CitigroupBoost TargetNeutral$21.00 ➝ $26.00
1/9/2023Bank of AmericaUpgradeUnderperform ➝ Neutral
10/6/2022CitigroupUpgradeSell ➝ Neutral$24.00 ➝ $17.00
9/26/2022Morgan StanleyDowngradeEqual Weight ➝ Underweight$20.00
8/1/2022Morgan StanleyLower TargetEqual Weight$22.00 ➝ $20.00
7/26/2022Stifel NicolausLower Target$26.00 ➝ $20.00
7/13/2022Morgan StanleyLower TargetEqual Weight$32.00 ➝ $22.00
4/18/2022Piper SandlerDowngradeNeutral ➝ Underweight$19.50 ➝ $21.30
4/11/2022Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $35.00
1/18/2022Morgan StanleyLower TargetEqual Weight$32.00 ➝ $30.00
12/7/2021Morgan StanleyLower TargetEqual Weight$34.00 ➝ $32.00
10/18/2021Bank of AmericaDowngradeNeutral ➝ Underperform$36.00 ➝ $32.00
10/11/2021Morgan StanleyLower TargetEqual Weight$37.00 ➝ $34.00
8/20/2021Piper SandlerLower TargetNeutral$20.00 ➝ $17.50
8/3/2021Morgan StanleyLower TargetEqual Weight$40.00 ➝ $37.00
7/9/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$40.00
6/14/2021CitigroupDowngradeNeutral ➝ Sell$30.00 ➝ $36.00
4/23/2021CitigroupLower Target$300.00 ➝ $36.00
3/25/2021Morgan StanleyBoost TargetOverweight$33.00 ➝ $38.00
1/11/2021Wolfe ResearchUpgradeUnderperform ➝ Market Perform
12/18/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$17.00 ➝ $18.00
12/15/2020Smith Barney CitigroupBoost Target$16.00 ➝ $30.00
11/11/2020CowenLower TargetMarket Perform$26.00 ➝ $20.00
11/10/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight
10/26/2020Morgan StanleyBoost TargetEqual Weight$24.00 ➝ $25.00
10/23/2020Smith Barney CitigroupLower Target$21.00 ➝ $16.00
10/13/2020Bank of AmericaUpgradeUnderperform ➝ Neutral
9/29/2020ABN AmroUpgradeSell ➝ Hold
7/27/2020Piper SandlerBoost TargetNeutral$15.00 ➝ $16.00
7/24/2020Stifel NicolausBoost TargetHold$15.00 ➝ $22.00
7/16/2020ScotiabankDowngradeSector Outperform ➝ Sector Perform$19.00
7/8/2020Morgan StanleyBoost TargetEqual Weight$18.00 ➝ $24.00
5/19/2020Morgan StanleyBoost TargetEqual Weight$12.00 ➝ $18.00
4/27/2020Royal Bank of CanadaReiterated RatingBuy
4/24/2020Stifel NicolausBoost TargetHold$14.00 ➝ $15.00
4/19/2020ScotiabankLower Target$40.00 ➝ $13.00
4/12/2020ScotiabankUpgradeSector Perform ➝ Sector Outperform$40.00 ➝ $13.00
4/7/2020Piper SandlerLower TargetNeutral$16.50 ➝ $7.50
3/18/2020Stifel NicolausLower TargetHold$17.00 ➝ $14.00
3/17/2020Evercore ISIDowngradeHold
3/17/2020JPMorgan Chase & Co.Lower TargetNeutral$39.00 ➝ $16.00
3/16/2020Morgan StanleyLower TargetEqual Weight$45.00 ➝ $12.00
3/13/2020CitigroupLower TargetNeutral$40.00 ➝ $11.00
3/10/2020Stifel NicolausLower TargetHold$40.00 ➝ $17.00
3/9/2020Bank of AmericaDowngradeBuy ➝ Underperform
1/31/2020CowenLower TargetMarket Perform$39.00 ➝ $36.00
1/30/2020Johnson RiceInitiated CoverageBuy
1/14/2020Bernstein BankInitiated CoverageMarket Perform$38.80
1/13/2020Sanford C. BernsteinInitiated CoverageMarket Perform$38.00 ➝ $38.80
1/2/2020Stifel NicolausDowngradeBuy ➝ Hold$50.00 ➝ $40.00
12/31/2019CowenLower TargetMarket Perform$42.00 ➝ $39.00
12/31/2019JPMorgan Chase & Co.Lower TargetNeutral$50.00 ➝ $47.00
12/10/2019CitigroupBoost TargetNeutral$44.00 ➝ $46.00
(Data available from 10/30/2019 forward)

News Sentiment Rating

0.81 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2024
  • 5 very positive mentions
  • 13 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2024
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2024
  • 8 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 9 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 8 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 11 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024

Current Sentiment

  • 11 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Core Laboratories logo
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Read More

Today's Range

Now: $19.47
Low: $19.30
High: $19.58

50 Day Range

MA: $18.55
Low: $16.52
High: $20.11

52 Week Range

Now: $19.47
Low: $13.82
High: $25.13

Volume

84,233 shs

Average Volume

431,390 shs

Market Capitalization

$913.14 million

P/E Ratio

33.00

Dividend Yield

0.21%

Beta

2.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Core Laboratories?

The following equities research analysts have issued research reports on Core Laboratories in the last twelve months: Bank of America Co., Piper Sandler, Stifel Nicolaus, StockNews.com, and TheStreet.
View the latest analyst ratings for CLB.

What is the current price target for Core Laboratories?

3 Wall Street analysts have set twelve-month price targets for Core Laboratories in the last year. Their average twelve-month price target is $18.00, suggesting a possible downside of 7.6%. Stifel Nicolaus has the highest price target set, predicting CLB will reach $22.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $15.00 for Core Laboratories in the next year.
View the latest price targets for CLB.

What is the current consensus analyst rating for Core Laboratories?

Core Laboratories currently has 1 sell rating and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for CLB.

What other companies compete with Core Laboratories?

Other companies that are similar to Core Laboratories include Transocean, California Resources, Black Stone Minerals, Liberty Energy and Crescent Energy. Learn More about companies similar to Core Laboratories.

How do I contact Core Laboratories' investor relations team?

Core Laboratories' physical mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company's listed phone number is (713) 328-2673 and its investor relations email address is [email protected]. The official website for Core Laboratories is www.corelab.com. Learn More about contacing Core Laboratories investor relations.